PlantArc Bio Ltd. (TLV: PLNT)
Israel
· Delayed Price · Currency is ILS · Price in ILA249.90
-1.80 (-0.72%)
Sep 8, 2024, 2:33 PM IDT
PlantArc Bio Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 4.74 | 4.78 | 0.1 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 113.57% | 4678.00% | - | - | - | - | Upgrade
|
| Cost of Revenue | 2.41 | 1.84 | - | - | - | - | Upgrade
|
| Gross Profit | 2.33 | 2.94 | 0.1 | - | - | - | Upgrade
|
| Selling, General & Admin | 2.1 | 2.19 | 2.22 | 1.81 | 0.3 | 0.32 | Upgrade
|
| Research & Development | 3.16 | 3.25 | 2.83 | 4.19 | 1.81 | 1.91 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | -0.21 | Upgrade
|
| Operating Expenses | 5.26 | 5.43 | 5.05 | 6 | 2.11 | 2.02 | Upgrade
|
| Operating Income | -2.94 | -2.5 | -4.95 | -6 | -2.11 | -2.02 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.43 | 0.43 | 0.06 | - | - | - | Upgrade
|
| Earnings From Equity Investments | - | -0.05 | -0.53 | -0.44 | -0.17 | -0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.03 | -0 | 0 | -0.01 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -2.52 | -2.11 | -5.44 | -6.46 | -2.3 | -2.15 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.46 | - | - | - | Upgrade
|
| Pretax Income | -2.52 | -2.11 | -4.98 | -6.46 | -2.3 | -2.15 | Upgrade
|
| Net Income | -2.52 | -2.11 | -4.98 | -6.46 | -2.3 | -2.15 | Upgrade
|
| Net Income to Common | -2.52 | -2.11 | -4.98 | -6.46 | -2.3 | -2.15 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | -0.00% | 0.12% | - | 1003.00% | - | - | Upgrade
|
| EPS (Basic) | -0.76 | -0.64 | -1.51 | -1.95 | -7.66 | -7.17 | Upgrade
|
| EPS (Diluted) | -0.76 | -0.64 | -1.51 | -1.95 | -7.66 | -7.17 | Upgrade
|
| Free Cash Flow | -0.85 | -3.56 | -3.44 | -4.22 | -1.78 | -2.1 | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -1.07 | -1.04 | -1.28 | -5.92 | -7.01 | Upgrade
|
| Gross Margin | 49.10% | 61.43% | 100.00% | - | - | - | Upgrade
|
| Operating Margin | -62.02% | -52.30% | -4952.00% | - | - | - | Upgrade
|
| Profit Margin | -53.16% | -44.12% | -4982.00% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -17.84% | -74.42% | -3442.00% | - | - | - | Upgrade
|
| EBITDA | -2.86 | -2.41 | -4.88 | -5.88 | -1.99 | -1.82 | Upgrade
|
| EBITDA Margin | -60.33% | -50.38% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.08 | 0.09 | 0.07 | 0.12 | 0.12 | 0.2 | Upgrade
|
| EBIT | -2.94 | -2.5 | -4.95 | -6 | -2.11 | -2.02 | Upgrade
|
| EBIT Margin | -62.02% | -52.30% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.